1985
DOI: 10.1159/000215650
|View full text |Cite
|
Sign up to set email alerts
|

Preliminary Results of the GPO-Trial for Treatment of Non-Testicular Germ-Cell Tumors in Children and Adolescents

Abstract: Germ cell tumors account for a 3% mortality rate of childhood malignancies. The combined chemotherapy, vinblastine, bleomycin and cis-platinum, is probably associated with more toxicity and treatment-induced mortality in children. Based on pharmacokinetic findings concerning the renal elimination of bleomycin and the well known cis-platinum nephrotoxicity, these two drugs were given sequentially. In addition, the cumulative dose of bleomycin was limited to 180 mg/m2. 61 patients entered the trial wh… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0
1

Year Published

1990
1990
2005
2005

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 6 publications
0
1
0
1
Order By: Relevance
“…Chemotherapy changed over the past few years [1,2] and there are different recommendations. According to the EAU guidelines on testicular cancer [3] 3 courses of PEB chemotherapy is the primary treatment of choice for patients with good-prognosis metastatic NSGCT.…”
Section: Discussionmentioning
confidence: 99%
“…Chemotherapy changed over the past few years [1,2] and there are different recommendations. According to the EAU guidelines on testicular cancer [3] 3 courses of PEB chemotherapy is the primary treatment of choice for patients with good-prognosis metastatic NSGCT.…”
Section: Discussionmentioning
confidence: 99%
“…Das Verhältnis der Flächenintegrale unter dem 7,5 kb-und 5,4 kb-Gipfel ist auf 0,8 im Vergleich zum korrespondierenden Wert von 1,4 bei der D S-Analyse der Plazenta vermindert.Abb. 2 Die korrespondierende denSitometrische Analyse des Southern Blot (Abb 1) verdeutlicht den homozygoten Verlust des 7,5 kb-Fragmentes in den Tumorzellen und den hemizygoten Verlust in den mononukleären Zellen des peripheren Blutes.juvante Chemotherapie, entsprechend dem MAKEl-Protokoll schloß sich an(9). Die Patientin lebt mit erneuten Lungenmetastasen.…”
unclassified